ORIGINAL PAPER
Comparison of diet in phenylketonuria and its costs with a traditional diet, based on 24-hour model meal plans
More details
Hide details
Publication date: 2018-07-20
Pediatr Pol 2018;93(3):203-216
KEYWORDS
ABSTRACT
Introduction:
A phenylalanine-restricted diet based on phenylalanine-free amino acid supplement and special low-protein food products with limited phenylalanine (Phe) content is the main treatment method in classical phenylketonuria (PKU). High diet costs are one of the common daily difficulties reported by patients and their caregivers.
Aim of the study:
The aim of this study was to compare 24-hour model meal plans and their costs, considering PKU children at different stages of development, with restriction-free diets of their peers.
Material and Methods:
Model meal plans were used for cost analysis; however, the disease-imposed constraints made the task of creating similar types of menus very challenging.
Results:
Meal plans for PKU children, which included specialised low-protein foods, were on average 41.49% more expensive than a traditional balanced diet for healthy children. The lowest cost difference was found in the menu for a 17-year-old child and the highest in the meal plan for a 10-year-old girl – 30.05% and 51.57%, respectively. The difference in the cost of the diet for a three-year-old was 42.85%. Results of the analysis demonstrate that following PKU dietary recommendations in order to maintain blood Phe concentration at the appropriate level generates a noticeable financial burden for patients and their caregivers.
Conclusions:
It is necessary to undertake an in-depth analysis of the costs of the therapeutic strategy used in PKU and consider the possibility of reimbursement of low-protein foods.
REFERENCES (31)
1.
van Spronsen FJ, van Wegberg AM, Ahring K i wsp. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocinol 2017; 5: 743-756.
2.
Ho G, Christodoulou J. Phenylketonuria: translating research into novel therapies. Transl Pediatr 2014; 3: 49-62.
3.
Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010; 376: 1417-1427.
4.
Nyhan WL, Barshop BA, Al-Aqeel AI. Phenylketonuria. W: Atlas of Inherited Metabolic Diseases. 3rd ed. Hodder Arnold, London 2012, str. 112-122.
5.
Cabalska B. Postępy w rozpoznawaniu i leczeniu fenylketonurii. Ped Pol 1984; 59: 905.
6.
Ołtarzewski M. Zaburzenia przemiany aminokwasów. Fenylokteonuria. Badanie przesiewowe noworodków. W: Wybrane choroby metaboliczne u dzieci. Cabalska B (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2002, str. 35-39.
7.
Acosta PB, Matalon KM. Nutrition management of patients with inherited disorders of aromatic amino acid metabolism: phenylketonuria. In: Nutrition Management of Inherited Metabolic Disorders. Jones and Bartlett Publishers, Sudbury 2010, str. 119-153.
8.
Żółkowska J, Sandecka E. Leczenie fenyloketonurii. W: Wybrane choroby metaboliczne u dzieci. Cabalska B (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2002, str. 58-94.
9.
Guillén-López S, López-Mejía LA, Ibarra-González I, Vela-Amieva M. Conventional phenylketonuria treatment. J Inborn Errors Metab Screen 2016; 4: 1-7.
10.
Pena MJ, de Almeida MF, van Dam E i wsp. Protein substitites for phenyloketonuria in Europe: access and nutritional composition. Eur J Clin Nutr 2016; 70: 785-789.
11.
Bélanger-Quintana A, Dokoupil K, Gokmen-Ozel H i wsp. Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers. Mol Genet Metab 2012; 105: 390-394.
12.
Szostak WB, Cichocka A. Modelowe diety lecznicze i diety specjalne dla dorosłych. Dobór produktów spożywczych w dietach leczniczych. W: Zasady prawidłowego żywienia chorych w szpitalach. Jarosz M (red.). Instytutu Żywności i Żywienia, Warszawa 2011, str. 120-125.
13.
Camp KM, Lloyd-Puryear MA, Huntington KL. Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Gen Metab 2012; 107: 3-9.
14.
Pena MJ, Ferreira Almeida M, van Dam E i wsp. Special low protein foods for phenylketonuria: availibility in Europe and examination of their nutritional profile. Orphanet J Rare Dis 2015; 10: 162.
15.
Żółkowska J. Postępowanie dietetyczne w klasycznej postaci fenyloketonurii. Stand Med 2014; 4: 555-564.
16.
Walter JH, Lachmann RH, Burgard P. Disorders of amino acid metabolism and transport. hyperphenylalaninemia. W: Inborn Metabolic Diseases: Diagnosis and Treatment. Saudubray G, van den Berge G, Walter JH (red.). Springer Medizin, Berlin Hilderberg 2012, str. 251-264.
17.
MacDonald A, Rylance G, Hall SK i wsp. Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet. Arch Dis Child 1996; 74: 412-417.
18.
Wykaz refundowanych leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych na dzień 1 maja 2017 r. Załącznik do obwieszczenia Ministra Zdrowia z dnia 26 kwietnia 2017 r. (poz. 51). Dostępne na:
http://www.mz.gov.pl (dostęp: 4.06.2017).
19.
Lau G, Lovelace H, Bosdet T i wsp. Comparison of the Average Weeky Cost of the PKU diet to the Nutritious Food Basket in Vancouver [Internet]. Vancouver: “Garrod Grant” – Canadian Association of Centers for the Management of Hereditary Metabolic Disorders; May 2006. Dostępne na:
http://www.garrod.ca/data/atta... (dostęp 4.06.2017).
20.
Eijgelshoven I, Demidras S, Smith TA i wsp. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab 2013; 19: 237-242.
21.
MacDonald A, Smith TA, de Silva S i wsp. The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK. Mol Genet Metab Rep 2016; 9: 1-5.
22.
Wang L, Zou H, Ye F i wsp. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study. J Inherit Metab Dis 2017; 40: 369-376.
23.
Sternal D, Grzywna T. Problemy rodziców w opiece nad dzieckiem z fenyloketonurią wynikające ze stosowania diety ubogofenyloalaninowej. Probl Pielęg 2007; 15: 26-31.
24.
Siatki centylowe dzieci i młodzieży w wieku 3–18 lat. Dostępne na: www.czd.pl (dostęp 4.06.2017).
25.
Jarosz M (red.). Normy żywienia dla populacji polskiej – nowelizacja. Wydawnictwo Lekarskie PZWL, Warszawa 2012.
26.
Healthy eating plate. Harvard School of Public Health. Dostępne na: www.hsph.harvard.edu (dostęp 4.06.2017).
27.
nstytut Żywności i Żywienia. Piramida zdrowego żywienia i aktywności fizycznej. Dostępne na: www.izz.waw.pl (dostęp 4.06.2017).
28.
Acosta PB, Yanicelli S. Protocol 1 – phenylketonuria (PKU). W: The Ross Metabolic Formula System Nutrition Support Protocols. 4th ed. Ross Products Division, Abbot Labboratories, Columbus 2001, str. 1-32.
29.
Acosta PB. Evaluation of nutrition status. W: Nutrition Management of Patients with Inherited Metabolic Disorders. Acosta PB (red.). Jones and Bertlett Publishers, Sudbury 2010, str. 67-98.
31.
Pieszko-Klejnowska M, Filipowicz J, Łysiak-Szydłowska. Wstępna ocena sposobu żywienia dzieci z fenyloketonurią. Żyw Człow Metab 2006; 33: 142-149.